Back to top
more

Lantheus (LNTH)

(Delayed Data from NSDQ)

$97.33 USD

97.33
648,582

+0.07 (0.07%)

Updated Aug 9, 2024 04:00 PM ET

After-Market: $97.39 +0.06 (0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (99 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

LHC Group (LHCG) Q2 Earnings & Revenues Miss Estimates

LHC Group's (LHCG) second-quarter results benefit from organic growth in hospice admissions. However, home health admissions decline organically.

Glaukos (GKOS) Q2 Earnings Miss Estimates, Revenues Beat

Glaukos' (GKOS) Q2 revenues fall year over year but beat estimates. Lower revenues along with higher expenses hurt margins significantly.

McKesson's (MCK) Q1 Earnings and Revenues Beat Estimates

McKesson's (MCK) fiscal first-quarter 2023 results benefit from segmental growth.

Inari Medical (NARI) Q2 Earnings Beat, CEO Transition in 2023

Inari Medical's (NARI) second-quarter results benefit from significant progress made across all its growth drivers.

Lantheus Holdings (LNTH) Q2 Earnings and Revenues Top Estimates

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 27.14% and 9.68%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

AmerisourceBergen (ABC) Q3 Earnings & Revenues Top Estimates

AmerisourceBergen's (ABC) fiscal third-quarter results benefit from segmental growth.

Is First Trust Small Cap Growth AlphaDEX ETF (FYC) a Strong ETF Right Now?

Smart Beta ETF report for FYC

Fresenius Medical's (FMS) Q2 Earnings Miss, Revenues Top

Fresenius Medical's (FMS) second-quarter earnings benefit from strong performance across all the geographic regions and segments. However, rising costs hurt margins.

PerkinElmer (PKI) Q2 Earnings and Revenues Surpass Estimates

PerkinElmer's (PKI) second-quarter results benefit from a solid performance at Discover & Analytics Solutions business.

DexCom (DXCM) Q2 Earnings Match Estimates, Revenues Miss

Despite the top line missing estimates, DexCom's (DXCM) second-quarter results reflected strong domestic and international revenue growth.

Zacks.com featured highlights Lantheus, Skyline Champion, CTS and U.S. Silica

Lantheus, Skyline Champion, CTS and U.S. Silica have been highlighted in this Screen of The Week article.

Baxter (BAX) Q2 Earnings Miss Estimates, Hilrom Adds $715 M

Baxter's (BAX) second-quarter results reflect the robust performance of the Medication Delivery business unit and Hilrom's businesses.

Surmodics (SRDX) Beats on Q3 Earnings, Revises FY22 View

Product sales primarily drive Surmodics' (SRDX) third-quarter top-line growth. However, the company expects softer demand for its products and services in the second half of 2022.

CONMED (CNMD) Down on In-Line Q2 Earnings & Lower 2022 View

CONMED's (CNMD) adjusted second-quarter earnings reflect strong segmental performance. However, unfavorable currency movement hurt sales growth. Inflationary or supply chain challenges hurt gross margin.

Vaishali Doshi headshot

4 Top-Ranked Liquid Stocks to Boost Portfolio Returns in 2022

Here are four top-ranked liquid stocks, Lantheus (LNTH), Skyline (SKY), CTS (CTS) and U.S. Silica Holdings (SLCA), which investors can add to their portfolio for solid returns.

What Makes Lantheus Holdings (LNTH) a Good Fit for "Trend Investing"

Lantheus Holdings (LNTH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Lantheus (LNTH) to Report Q2 Results: What's in the Cards?

Lantheus' (LNTH) Q2 performance is likely to gain from the continued uptake of PYLARIFY and DEFINITY.

Lantheus Holdings, Inc. (LNTH) Hit a 52 Week High, Can the Run Continue?

Lantheus Holdings (LNTH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Best Growth Stocks to Buy for July 21st

LNTH, PEB, and AFYA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 21, 2022.

Lantheus Holdings (LNTH) Earnings Expected to Grow: Should You Buy?

Lantheus Holdings (LNTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now?

Smart Beta ETF report for FYX

Best Growth Stocks to Buy for July 18th

LNTH, AFYA, and DELL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 18, 2022.

Best Growth Stocks to Buy for July 15th

: DLTR, LNTH and MRK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 15, 2022.